Chronic cough, defined as a cough persisting beyond eight weeks, presents a significant diagnostic and therapeutic challenge in clinical practice due to its multifactorial etiology. This article aims to elucidate a comprehensive approach to diagnose and manage chronic cough effectively.
The diagnostic approach should be systematic and patient-centric. A detailed history and physical examination are crucial to identify potential etiologies. The clinician should consider common causes like gastroesophageal reflux disease (GERD), asthma, upper airway cough syndrome (UACS), and non-asthmatic eosinophilic bronchitis (NAEB). However, rare causes like lung cancer, sarcoidosis, and idiopathic pulmonary fibrosis should not be overlooked. Laboratory tests, imaging studies, and pulmonary function tests can be instrumental in identifying the underlying cause.
Management of chronic cough should be tailored based on the identified cause. For example, proton pump inhibitors may be beneficial in GERD-associated cough, while inhaled corticosteroids are the mainstay for asthma or NAEB related cough. Antihistamines and decongestants can be effective for UACS. In refractory cases or when the cause is unclear, referral to a pulmonologist or otolaryngologist may be necessary.
Education plays a pivotal role in managing chronic cough. Patients should be informed about the chronic nature of their condition, potential triggers, and the importance of adherence to therapy. Lifestyle modifications like smoking cessation, weight loss, and dietary changes can also significantly impact symptom control.
Chronic cough is a complex condition requiring a comprehensive, patient-centric approach for effective diagnosis and management. A thorough understanding of potential etiologies and appropriate therapeutic strategies can significantly improve patient outcomes. Furthermore, patient education and lifestyle modifications are crucial adjuncts to pharmacological therapy.
1.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
2.
younger kidney cancer survivors are more susceptible to heart problems.
3.
Gene therapy for glioblastoma is effectively created by researchers.
4.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
5.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
1.
Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies
2.
Clinical Guidance for Survivorship-Focused Cancer Care
3.
Transformative Insights in Oncology in Daily Practice
4.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
5.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation